State PA
Clinical Trials in Pennsylvania
Recruiting clinical trials with at least one study location in Pennsylvania. Data updated daily from ClinicalTrials.gov.
Top Conditions in Pennsylvania
NCT07323654 Phase 2
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Sev...
Condition
Eosinophilic Asthma
Enrollment
264 pts
Location
United States
Sponsor
Kymera Therapeutics, Inc.
NCT05004129 Phase 2, Phase 3
Recruiting
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dyst...
Condition
Congenital Myotonic Dystrophy
Enrollment
76 pts
Location
United States, Australia, Canada
Sponsor
AMO Pharma Limited
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
NCT06444594 EARLY_Phase 1
Recruiting
Transient Receptor Potential Channels
Condition
Aging
Enrollment
45 pts
Location
United States
Sponsor
Penn State University
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT07116746 Phase 2
Recruiting
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase ...
Condition
Gout
Enrollment
25 pts
Location
United States
Sponsor
Arthrosi Therapeutics
NCT06896188 Phase 1
Recruiting
9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With ...
Condition
Pancreatic Adenocarcinoma
Enrollment
12 pts
Location
United States
Sponsor
Anwaar Saeed
NCT06978127 N/A
Recruiting
Technology Assisted Collaborative Care Intervention to Improve Patient-centered ...
Condition
Chronic Kidney Disease Requiring Hemodialysis
Enrollment
424 pts
Location
United States
Sponsor
University of Pittsburgh
NCT07219173 Phase 2
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With...
Condition
Asthma
Enrollment
531 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT05572073 N/A
Recruiting
Otoferlin Gene-mediated Hearing Loss Natural History Study
Condition
Sensorineural Hearing Loss, Bilateral
Enrollment
150 pts
Location
United States, Australia, Germany
Sponsor
Akouos, Inc.
NCT05456503 Phase 3
Recruiting
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-262...
Condition
Frontotemporal Lobar Degeneration
Enrollment
72 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Condition
Narcolepsy Type 1
Enrollment
96 pts
Location
United States, Canada
Sponsor
Centessa Pharmaceuticals (UK)
NCT06682988 Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants ...
Condition
Advanced High-Grade Epithelial Ovarian
Enrollment
110 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT05184569 Phase 1
Recruiting
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Condition
Semantic Dementia
Enrollment
64 pts
Location
United States
Sponsor
Peter Ljubenkov, MD
NCT00345553 N/A
Recruiting
Biliary Atresia Study in Infants and Children
Condition
Biliary Atresia
Enrollment
1,265 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT05558371 N/A
Recruiting
International CDKL5 Clinical Research Network
Condition
CDKL5
Enrollment
1,000 pts
Location
United States, Australia
Sponsor
University of Colorado, Denver
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT04929028 Phase 2
Recruiting
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Condition
AIDS-Related Anal Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04064060 Phase 3
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Ot...
Condition
Myelodysplastic Syndromes (MDS)
Enrollment
665 pts
Location
United States, Australia, Belgium
Sponsor
Celgene
NCT07222982 N/A
Recruiting
Social Groups for Autistic Young Adults (SDARIYA)
Condition
Autism Spectrum Disorder
Enrollment
54 pts
Location
United States
Sponsor
Drexel University
NCT05836324 Phase 1
Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Met...
Condition
Solid Tumors
Enrollment
408 pts
Location
United States, Denmark, France
Sponsor
Incyte Corporation
NCT06385886 N/A
Recruiting
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for S...
Condition
Sickle Cell Disease
Enrollment
500 pts
Location
United States
Sponsor
RTI International
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company